LifeArc and Action Medical Research launch funding call for research into rare diseases in children

LifeArc, a UK-based medical research charity, and children’s charity Action Medical Research are funding research projects that could lead to new interventions (therapeutics, diagnostics and devices) to improve the lives of children living with a rare disease.

The charities have announced that £1m of funding will be available for translational research projects from across the UK focused on children’s rare diseases. They are seeking applications by the 3^rd March 2020 from scientists who require additional funding to progress promising research projects.

This is the second funding call issued by both organisations. Last year, two projects were jointly funded; one into gene therapy for a progressively debilitating condition called Hunter syndrome, and another into a new targeted drug combination for a rare form of acute leukaemia.

Dr Catriona Crombie, Head of LifeArc’s Philanthropic Fund said: “Our Philanthropic Fund was established to support academics in translating fundamental science into new treatments for rare diseases.

“This partnership with Action Medical Research allows us to combine our different areas of skills and expertise to further promising research to benefit younger patients.”

-Ends-

For further information:

LifeArc